Answers are grounded in this paper and cite their sources.
Clinical practice guideline reveals 36 management recommendations in hereditary hemorrhagic telangiectasia, highlighting standardized care across six clinical domains.
The expert panel generated and approved 6 new recommendations for each of the following 6 priority topic areas: epistaxis, gastrointestinal bleeding, anemia and iron deficiency, liver VMs, pediatric care, and pregnancy and delivery (36 total). The recommendations highlight new evidence in existing topics from the first International HHT Guidelines and provide guidance in 3 new areas: anemia, pediatrics, and pregnancy and delivery. These recommendations should facilitate implementation of key components of HHT care into clinical practice.
No takes yet. Share an insight, caveat, or question.
Faughnan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: